Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pulse Biosciences CS
(NQ:
PLSE
)
15.63
-0.11 (-0.70%)
Streaming Delayed Price
Updated: 11:04 AM EDT, Oct 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pulse Biosciences CS
< Previous
1
2
3
4
5
Next >
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Pulse Biosciences, Inc. (PLSE)
February 22, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
Shareholder Alert: Robbins LLP Reminds Investors that Pulse Biosciences, Inc. (PLSE) is Being Sued for Misleading Shareholders
February 21, 2022
From
Robbins LLP
Via
Business Wire
PLSE Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm
February 21, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm
February 21, 2022
From
The Schall Law Firm
Via
Business Wire
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm
February 18, 2022
From
The Schall Law Firm
Via
Business Wire
Shareholder Alert: Robbins LLP Informs Investors that Pulse Biosciences, Inc. (PLSE) is Being Sued for Misleading Shareholders
February 18, 2022
From
Robbins LLP
Via
Business Wire
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Pulse Biosciences, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – PLSE
February 18, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
PULSE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Pulse Biosciences, Inc. and Encourages Investors to Contact the Firm
February 17, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
ALERT: Pulse Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PLSE
February 17, 2022
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Pulse Biosciences, Inc. (PLSE) Investors
February 17, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Pulse Biosciences, Inc. (PLSE) Investors
February 17, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
PLSE CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Pulse Biosciences, Inc.
February 17, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer
February 15, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
February 14, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
February 14, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
PULSE ALERT: Bragar Eagel & Squire, P.C. is Investigating Pulse Biosciences, Inc. on Behalf of Pulse Stockholders and Encourages Investors to Contact the Firm
February 13, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
PULSE ALERT: Bragar Eagel & Squire, P.C. is Investigating Pulse Biosciences, Inc. on Behalf of Pulse Stockholders and Encourages Investors to Contact the Firm
February 11, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
The Law Offices of Frank R. Cruz Continues Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
February 11, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. (PLSE) Investors of Investigation
February 10, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. (PLSE) Investors of Investigation
February 09, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
February 08, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
February 08, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
February 08, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Pulse Biosciences Provides an Update on Recent FDA 510(k) Submission
February 08, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 01, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces Preliminary Fourth Quarter and Full Year 2021 Financial and Operational Results
January 11, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences to Participate in the Stephens Annual Investment Conference
November 18, 2021
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Reports Third Quarter 2021 Financial Results
November 15, 2021
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences to Present at the Stifel 2021 Virtual Healthcare Conference
November 04, 2021
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Schedules Third Quarter 2021 Financial Results Conference Call for November 15, 2021
November 02, 2021
From
Pulse Biosciences, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.